CTRI/2021/11/038260
Not yet recruiting
未知
Evaluating effect of Escitalopram and Desvenlafaxine on anxiety and BDNF level in depression with comorbid anxiety â?? An open label, randomized, parallel group, clinical study - NI
Dr Chaitali Chindhalore0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: F321- Major depressive disorder, singleepisode, moderate
- Sponsor
- Dr Chaitali Chindhalore
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Drug naïve patients of either gender having age between 18 to 70 years with a clinical diagnosis of depressive episode as per ICD 10 (F 32\)
- •2\.Hamilton Scale of Rating Depression (HAM\-D) score \>20;
- •3\.Baseline Hamilton Anxiety Rating Scale (HAM\-A) score \> 14
Exclusion Criteria
- •1\.Subjects with other coexistent psychiatric disorders as described by ICD 10, (World Health Organization, 2008\)
- •2\.Subjects on antianxiety medication within washout period
- •3\.Use of psychoactive substances except tobacco and caffein
- •4\.Concurrent debilitating illnesses like chronic renal failure, malignancy, cirrhosis etc
- •5\.Subjects on drugs which are known to interact with the study medications
- •6\.History of allergy to study medication
- •7\.Lactating and pregnant women
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Efficacy of Escitalopram, Venlafaxine and Buspirone in Irritable Bowel SyndromeIrritable bowel syndrome.Irritable bowel syndromeIRCT20150630022991N10Babol University of Medical Sciences90
Completed
Phase 3
Evaluation of the effects of citalopram and doxepin in patients with chronic obstructive pulmonary diseaseIRCT20161023030452N2Zanjan University of Medical Sciences72
Recruiting
Phase 3
Treatment of depressive symptoms in patients with heart failureDepression.Major depressive disorder, single episode, mildF32.0IRCT20190525043700N5Babol University of Medical Sciences80
Completed
Phase 2
Evaluation of the effect of Escitalopram versus placebo trial on changing the neuroticismeuroticism or neuroticism.Post-traumatic stress disorder, acuteF43.11IRCT20211208053331N1Ahvaz University of Medical Sciences172
Completed
Phase 4
Comparison Of Two Anti Depressant Drugs In Major Depressive DisorderHealth Condition 1: null- Major Depressive DisorderCTRI/2018/02/011662Government Medical College50